Attachment Solution for Cytological Sample Adhesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods face challenges in maintaining cytological and histological samples adhered to substrates during analysis, which is crucial for obtaining valuable diagnostic information.

Innovation Solution

An attachment solution comprising an attachment base, such as alcohol or ketones, combined with a nonsteroidal anti-inflammatory drug and an anti-coagulant, is used to adhere samples to substrates, preventing cross-linking of proteins and allowing for efficient fixation and imaging without additional processing steps like antigen retrieval.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional diagnostic methods are used to analyze histological and cytological samples, then sample processing can proceed through standard protocols, but the samples may not remain adhered to the substrate, resulting in loss of valuable diagnostic information

Engineering Contradiction:
Improvesample adherence to substrateVSAvoiddiagnostic information
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent applies preliminary action by treating the substrate with a specific coating composition before sample application. This pre-treatment creates adhesive properties on the substrate surface that ensure sample adherence during subsequent processing steps, preventing sample loss and preserving diagnostic information throughout the diagnostic workflow

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses a coating composition as an intermediary substance between the substrate and the biological sample. This coating layer acts as a mediator that promotes adhesion between the sample and substrate while maintaining compatibility with subsequent diagnostic processing steps, solving the adherence problem without interfering with diagnostic analysis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If additional processing steps like antigen retrieval are performed to ensure sample adherence, then sample retention on substrate is improved, but the complexity and time of the diagnostic process increases

Engineering Contradiction:
Improvesample retention on substrateVSAvoidprocessing steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent eliminates the need for subsequent antigen retrieval steps by performing the adhesion-promoting action in advance through substrate coating. This preliminary treatment ensures sample retention throughout processing without requiring additional complex steps later in the workflow, reducing overall process complexity while maintaining reliable sample adherence

Inventive Principle:
Principle #10Preliminary action

3Ease of manufacture

If standard substrate coating methods are used, then substrate preparation is simple, but the samples do not adhere reliably during subsequent processing

Engineering Contradiction:
Improvesubstrate preparationVSAvoidsample adherence
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent uses a composite coating composition containing multiple components (such as poly-L-lysine, gelatin, and other adhesion-promoting substances) applied to the substrate. This composite material provides reliable sample adherence while maintaining compatibility with standard substrate preparation methods, achieving both ease of manufacture and reliable sample retention

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution effectively adheres samples to substrates, enabling reliable diagnostic analysis by preventing sample cracking and coagulation, allowing for rapid curing and compatibility with various analysis techniques.

Implementation Method 1

The attachment solution includes an attachment base and a nonsteroidal anti-inflammatory drug... The sample is dispensed onto an analysis platform as one or more droplets and cured. The sample may then be fixed...

Methodology Applied
Scientific EffectAdhesion: Adhesive

Implementation Method 2

An attachment solution comprising an attachment base, such as alcohol or ketones, combined with a nonsteroidal anti-inflammatory drug and an anti-coagulant, is used to adhere samples to substrates, preventing cross-linking of proteins

Methodology Applied
Scientific EffectChemical inhibition:

Implementation Method 3

An attachment solution comprising an attachment base, such as alcohol or ketones, combined with a nonsteroidal anti-inflammatory drug and an anti-coagulant, is used to adhere samples to substrates

Methodology Applied
Scientific EffectAnticoagulation:

Implementation Method 4

The sample is dispensed onto an analysis platform as one or more droplets and cured

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS10101248B1Solution and method for adhering suspension components to a substrate
Publication Date: 2018.10.16 RARECYTE INC
  • US10101248B1 patent drawing
  • US10101248B1 patent drawing
  • US10101248B1 patent drawing

AI summary

This disclosure is directed to a method and an attachment solution for adhering a cytological or histological sample, such as buffy coat, to a substrate, such as a microscope slide. The attachment solution includes an attachment base, an anti-coagulant, and a nonsteroidal anti-inflammatory drug. The attachment base may be an alcohol, an acid, an oxidizer, an organohalogen, a ketone, or any combination thereof. Once a sample is obtained, the sample may be re-suspended in the attachment solution or the attachment solution may be added to the sample. The sample may then be dispensed onto an analysis platform as one or more droplets and cured.